Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Innate Pharma (IPHYF)

Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Innate Pharma 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 FRA

www.innate-pharma.com Employees: 179 P: 33-4-30-30-30-30

Description:

Innate Pharma S.A. is a biopharmaceutical company. It develops drugs for treatment of cancer and inflammatory diseases. The company specializes in the development of first-in-class therapeutic antibodies targeting receptors and pathways controlling the activation of the innate immune system. Innate Pharma S.A. is headquartered in Marseilles, France.

Key Statistics

Overview:

Market Capitalization, $K 180,076
Enterprise Value, $K 103,656
Shares Outstanding, K 80,212
Annual Sales, $ 66,710 K
Annual Net Income, $ -8,190 K
EBIT, $ 0 K
EBITDA, $ -8,200 K
60-Month Beta 1.20
% of Insider Shareholders 31.89%
% of Institutional Shareholders 0.00%
Float, K 54,632
% Float 68.11%
Short Volume Ratio 0.67

Growth:

1-Year Return -25.17%
3-Year Return -69.16%
5-Year Return 0.00%
5-Year Revenue Growth -39.88%
5-Year Earnings Growth -266.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 09/12/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IPHYF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -12.28%
Debt/Equity 0.00
Price/Sales 2.65
Price/Cash Flow N/A
Price/Book 3.14
Book Value/Share 0.70
Interest Coverage -3.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar